Stimulatory effect of an endogenous peptide in rat pancreatic juice on pancreatic enzyme secretion in the presence of atropine: Evidence for different mode of action of stimulation from exogenous trypsin inhibitors

1984 ◽  
Vol 118 (2) ◽  
pp. 532-537 ◽  
Author(s):  
Tohru Fushiki ◽  
Shin-ichi Fukuoka ◽  
Kazuo Iwai
Gut ◽  
1984 ◽  
Vol 25 (8) ◽  
pp. 867-873 ◽  
Author(s):  
L Gullo ◽  
P Priori ◽  
P L Costa ◽  
G Mattioli ◽  
G Labo

1986 ◽  
Vol 116 (8) ◽  
pp. 1540-1546 ◽  
Author(s):  
Shin-Ichi Fukuoka ◽  
Masahiro Tsujikawa ◽  
Tohru Fushiki ◽  
Kazuo Iwai

1989 ◽  
Vol 256 (2) ◽  
pp. G430-G435 ◽  
Author(s):  
L. Lu ◽  
D. Louie ◽  
C. Owyang

Diversion of bile pancreatic juice from the duodenum in rats stimulates cholecystokinin (CCK) release and pancreatic enzyme secretion. Intraduodenal perfusion of trypsin inhibits the release of CCK and pancreatic enzyme secretion. We hypothesized that the increased pancreatic enzyme secretion after pancreatic juice diversion is mediated by a trypsin-sensitive peptide secreted by the small intestine that stimulates release of CCK. To test this hypothesis, rats were surgically prepared with bile-pancreatic cannula and intestinal fistulas. Diversion of bile-pancreatic juice stimulated amylase output fivefold above basal and increased plasma CCK from a basal of 0.5 +/- 0.05 pM to 14 +/- 5 pM. Rapid perfusion (3 ml/min) of the duodenum with phosphate-buffered saline reversed the increase in amylase output and lowered the plasma CCK to 1.2 +/- 0.2. Administration of intestinal perfusate (3 ml/min) collected from a donor rat into the duodenum of a recipient rat with diversion of bile pancreatic juice increased amylase output threefold above basal and increased plasma CCK. The stimulatory activity of the intestinal perfusate was inactivated by treatment with trypsin but not by amylase or lipase. In addition, boiling did not alter the stimulatory activity of the intestinal perfusate. Perfusion of intestinal perfusate from donor rats pretreated with atropine did not stimulate amylase output and CCK release in recipient rats. By use of molecular membrane exclusion filters, stimulatory activity was retained (between 1,000 and 5,000). These results indicate that feedback regulation of pancreatic enzyme secretion is mediated by a CCK releasing peptide whose secretion from the duodenum is cholinergically mediated. This peptide is trypsin sensitive and has a molecular weight between 1,000 and 5,000.


1962 ◽  
Vol 202 (6) ◽  
pp. 1077-1082 ◽  
Author(s):  
R. L. Lyman ◽  
Sue Stewart Wilcox ◽  
E. Ranker Monsen

In previous experiments, rats fed soybean trypsin inhibitor exhibited an exaggerated secretion of principal pancreatic digestive enzymes, as measured by the enzyme activities of the pancreas and intestine shortly after feeding. The present experiments studied the effect of trypsin inhibitors from egg white and lima bean on this pancreatic response in the rat. The influence of atropine and bilateral vagotomy on such secretion was also investigated. Both egg white and lima bean trypsin inhibitors evoked pancreatic enzyme secretion similar to that produced by soybean trypsin inhibitor. Inactivation of the inhibitors by reaction with crystalline trypsin prior to feeding did not impair the response. The physiological activity of these substances appeared to be closely associated with their trypsin inhibitor activity, yet inactivation of endogenous trypsin in the small intestine seemed not to be necessary for the response. Although vagotomy or a parasympathetic blocking agent did not suppress the pancreatic response to soybean trypsin inhibitor, no evidence for the release of a humoral factor by the inhibitor was obtained by cross-circulation observations.


2020 ◽  
Vol 1 (30) ◽  
pp. 30-36
Author(s):  
E. A. Krylova ◽  
D. V. Aleinik

The article presents the results of a study of the effectiveness of the use of an inhibitor of pancreatic enzyme secretion of octreotide (Octrade) for the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). It was shown that the administration of Octrade at a dose of 0.3 mg in 500 ml of 0.9 % NaCl by continuous intravenous infusion for 7 hours and then 0.1 mg of Octrade subcutaneously at 6 and 12 hours after the end of intravenous infusion significantly reduced the frequency of pancreatitis (4.0 % and 22.2 %; p < 0.05) and hyperamylasemia (8.0 % and 25.9 %; p < 0.05) after ERCP. It is concluded that Octrade is effective in preventing the development of pancreatitis and hyperamilasemia after ERCP.


Sign in / Sign up

Export Citation Format

Share Document